Compare MLYS & IMXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLYS | IMXI |
|---|---|---|
| Founded | 2019 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 469.3M |
| IPO Year | 2023 | 2016 |
| Metric | MLYS | IMXI |
|---|---|---|
| Price | $28.26 | $15.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $48.67 | $16.67 |
| AVG Volume (30 Days) | ★ 1.3M | 349.4K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.43 | N/A |
| EPS | N/A | ★ 1.08 |
| Revenue | N/A | ★ $319,601,000.00 |
| Revenue This Year | N/A | $0.28 |
| Revenue Next Year | N/A | $0.41 |
| P/E Ratio | ★ N/A | $14.64 |
| Revenue Growth | N/A | ★ 16.68 |
| 52 Week Low | $10.44 | $8.58 |
| 52 Week High | $47.65 | $15.90 |
| Indicator | MLYS | IMXI |
|---|---|---|
| Relative Strength Index (RSI) | 57.70 | 55.78 |
| Support Level | $26.85 | $15.73 |
| Resistance Level | $30.53 | $15.81 |
| Average True Range (ATR) | 1.53 | 0.05 |
| MACD | 0.61 | -0.01 |
| Stochastic Oscillator | 85.99 | 42.86 |
Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.
International Money Express Inc is an omnichannel money remittance services company focused on the United States of America to Latin America and the Caribbean corridor, which includes Mexico, Central and South America and the Caribbean. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.